Major depressive disorder (MDD) in pediatric populations represents a significant public health concern. Rates of MDD rise dramatically in adolescence, with an estimated lifetime prevalence of 15% in adolescents aged 15 to 18.
Oded Gonen, PhD
Advertisement
Articles by Oded Gonen, PhD
Advertisement
Latest Updated Articles
- The Neurochemistry of Pediatric Major Depressive Disorder
Published: March 1st 2008 | Updated:
Advertisement
Advertisement
Trending on Psychiatric Times
1
Lithium-Loaded Gold Nanoparticle Nasal Spray to Treat Neuropsychiatric Diseases
2
The Trial of ChatGPT: What Psychiatrists Need to Know About AI, Suicide, and the Law
3
LSD for Generalized Anxiety Disorder: New Findings Review With Maurizio Fava, MD
4
Suicide: Can Emergency Departments Assist in its Prevention?
5
